Clinical Trials Browser

Phase 1/2 × Mouth Neoplasms × Celecoxib × Clear all

NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Phase 1/2 Completed

21 enrolled 10 charts

Mouth Neoplasms